References
- Wallace S L. Colchicine. Semin Arthritis Rheum 1974; 3: 369–81
- Zemer D, Revach M, Pras M, Modan M, Schor S, Sohar E. et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N. Engl J Med 1974; 291: 932–4
- Dinarello C A., Wolff S M., Goldfinger S E., Dale D C., Ailing D W. Colchicine therapy for familial Mediterranean fever–a double blind trial. N Engl J Med 1974; 291: 934–7
- Levy M, Spino M, Read S E. Colchicine: a state-of-the-art review. Pharmacotherapy 1991; 11: 196–211
- Peters R S., Lehmann T JA, Schwabe A D. Colchicine use for familial Mediterranean fever. West J Med 1983; 138: 43–6
- Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 1001–5
- Kershenobich D, Uribe M, Suarez G I., Mata J H., Perez-Tamayo R, Rojkind M. Treatment of cirrhosis with colchicine: a double-blind randomized trial. Gastroenterology 1979; 77: 532–6
- Kaplan M M., Ailing D W., Zimmerman H J., Wolfe H J., Sepersky R A., Hirsch G S., et al. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 1986; 315: 1448–54
- Warnes T W., Smith A, Lee F I., Haboubi N Y., Johnson P J., Hunt L. A controlled trial of colchicine in primary biliary cirrhosis–trial design and preliminary report. J Hepatol 1987; 5: 1–7
- Kershenobich D, Vargas F, Garcia-Tsao G, Gent M, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988; 318: 1709–13
- Zifroni A, Schaffner F. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy. Hepatology 1991; 14: 990–3
- Bodenheimer H, Schaffner F, Pezzulo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 1988; 95: 124–9
- Walker P R., Boynton A L., Whitfield J F. The inhibition by colchicine of the initiation of DNA synthesis by hepatocytes in regenerating rat liver and by cultivated WI-38 and C3H10T 1/2 cells. J Cell Physiol 1977; 93: 89–98
- Mourelle M, Rojkind M, Rubalcara B. Colchicine improves the alterations in the liver adenylate cyclase system of cirrhotic rats. Toxicology 1981; 21: 213–22
- Harris E D., Krane S M. Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthritis Rheum 1971; 14: 669–84
- White R R., Leon I, Kuhn C. Effects of colchicine, vinblastine, D20 and cytocholasin B on elastase secretion, protein synthesis and fine structure of mouse alveolar macrophages. J Reticulo-endothel Soc 1971; 29: 295–301
- Kershenobich D, Rojkind M, Quiroga A, Alcocer-Varela J. Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis. Hepatology 1990; 11: 205–9
- Lhermitte M, Bernier J L., Mathieu D, Mathieu-Nolf M, Erb F, Roussel P. Colchicine quantitation by high-performance liquid chromatography in human plasma and urine. J Chromatogr 1985; 342: 416–23
- Achtert G, Scherrmann J M., Christen M O. Pharmacokinetics/ bioavailability of colchicine in healthy male volunteers. Eur J Drug Metab Pharmacokinet 1989; 14: 317–22
- Leighton J A., Bay M K., Maldonado A L., Schenker S, Speeg K V. Colchicine clearance is impaired in alcoholic cirrhosis. Hepatology 1991; 14: 1013–5
- Bruce A M. The fate of colchicine in the body. J Clin Invest 1942; 21: 646–7
- Fleischmann W, Price H, Fleischmann S. Pathways of excretion of colchicine in the golden hamster. Pharmacology 1968; 1: 48–52
- Hunter A L., Klaassen C D. Biliary excretion of colchicine. J Pharmacol Exp Ther 1975; 192: 605–17
- Scherrmann J M., Boudet L, Nguyen-Hoang-Nam Fournier P E. A sensitive radioimmunoassay for colchicine. J Pharm Pharmacol 1980; 32: 800–2
- Heinzel G, Woloszczak R, Thomann P. Pharmacokinetic and pharmacodynamic data analysis system TOPFIT 2.0. Gustav Fischer Verlag, Stuttgart 1993
- SAS Institute Inc. SAS procedures guide and SAS/STAT guide for personal computers. The Institute, Cary, NC 1987, Version 6
- Leighton J A., Bay M K., Maldonado A L., Schenker S, Speeg K V. The effect of liver dysfunction on colchicine pharmacokinetics in the rat. Hepatology 1990; 11: 210–4
- Wallace S L., Omokoku B, Ertel N H. Colchicine plasma levels: implications as to pharmacology and mechanisms of action. Am J Med 1970; 48: 443–8
- Schonharting M, Pfaender P, Rieker A, Siebert G. The oxidative formation of products from Colchicine in the Udenfriend system. Hoppe-Seylers Z Physiol Chem 1973; 354: 421–36
- Wallace S L., Ertel N H. Plasma levels of colchicine after oral administration of a single dose. Metabolism 1973; 5: 749–53
- Thomas G, Girre C, Scherrmann J M., Francheteau P, Steimer J L. Zero-order absorption and linear disposition of oral colchicine in healthy volunteers. Eur J Clin Pharmacol 1989; 37: 79–84
- Bourdon R, Galliot M, Scherrmann J M. Clinical pharmacology of colchicine [abstract]. Toxicol Lett 1980; 116, Spec. Issue 1
- Sabouraud A, Rochdi M, Urtizerba M, Christen M O., Achtert G, Scherrmann J M. Pharmacokinetics of colchicine: a review of experimental and clinical data. Z Gastroenterol 1992; 30: 35–9, Suppl 1
- Speeg K V., Maldonado A L., Liaci J, Muirhead D. Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. Hepatology 1992; 15: 899–903
- Halkin H, Dany S, Greenwald M, Shnaps Y, Tirosh M. Colchicine kinetics in patients with familial Mediterranean fever. Clin Pharmacol Ther 1980; 28: 82–7
- Katz E Z., Ehrenfeld M, Levy M, Eliakim M. Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis. Arthr Rheum 1982; 25: 227–31